CD38 and COVID-19: Compared to HCs, COVID-19 patients were characterized by a low level of central memory T4 cells (Figure 1A) and high percentages of activated (CD38+ and HLA-DR+CD38+, Figures 1B, C) and exhausted (PD-1+, Figure 1D) T4 cells.